Benign Pigmented Lesions
8
0
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
13%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
Evaluation of Laser Treatment for Benign Pigmented Lesions by Non-invasive, Cellular Resolution Optical Coherence Tomography
Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands
Lutronic LaseMD for Treatment of Benign Pigmented Lesions
Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment
785nm Picosecond Laser for Treatment of Benign Pigmented Lesions
Picosecond Laser for Ttreatment of Benign Pigmented Lesions